FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury
Links shared publicly online about this topic.
- 1,140total visits
FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury
fda.gov —
FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury
View full resource at fda.gov
Tags: Liver, Obesity Medication, Drug, FDA, Xenical
Most Recently Shared on May 27, 2010 at 2:13 pm By:
FDA: Rare Cases of Liver Injury Reported with Use of Xenical, Alli. http://lb.vg/rx61z
Advertisement
